Patients were randomized 2:1 to receive fitusiran prophylaxis or to continue on-demand clotting factor concentrates for a total of nine months
When market participants perceive a lack of boundary discipline, they assign greater probability to forced product removals, fines, injunctions, and increased ongoing compliance costs
However, when it comes to pregnancy, the existing literature urges caution due to the limited data on the safety of GLP-1 medications during this crucial period
MitraSPaulSRoySSutradharHBin EmranTNainuFet al
No, its not safe: The expiration date is a safety guideline
In a cohort of over 150,000 patients, the researchers identified no difference in the risk following initiation of different GLP-1 agents among these adults, despite the differences in systemic efficacy among the examined GLP-1 receptor agonist medications